Live Breaking News & Updates on News ratings for acurx pharmaceuticals daily

Stay informed with the latest breaking news from News ratings for acurx pharmaceuticals daily on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in News ratings for acurx pharmaceuticals daily and stay connected to the pulse of your community

HC Wainwright Trims Acurx Pharmaceuticals (NASDAQ:ACXP) Target Price to $12.00

HC Wainwright Trims Acurx Pharmaceuticals (NASDAQ:ACXP) Target Price to $12.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Acurx-pharmaceuticals-price-performance , Prospect-financial-services , Global-capital , Acurx-pharmaceuticals , Blackrock-inc , Vanguard-group-inc , News-ratings-for-acurx-pharmaceuticals-daily , Northern-trust-corp , Acurx-pharmaceuticals-inc , Free-report , Financial-services

Acurx Pharmaceuticals (NASDAQ:ACXP) Price Target Cut to $12.00

Acurx Pharmaceuticals (NASDAQ:ACXP) Price Target Cut to $12.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Northern-trust-corp , Vanguard-group-inc , News-ratings-for-acurx-pharmaceuticals-daily , Acurx-pharmaceuticals-inc , Osaic-holdings-inc , Acurx-pharmaceuticals-company-profile , Acurx-pharmaceuticals-trading-down , Prospect-financial-services , Nasdaq , Acurx-pharmaceuticals , Blackrock-inc

Acurx Pharmaceuticals' (ACXP) "Buy" Rating Reaffirmed at HC Wainwright

Acurx Pharmaceuticals' (ACXP) "Buy" Rating Reaffirmed at HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Acurx-pharmaceuticals-company-profile , Blackrock-inc , Sigma-planning-corp , Northern-trust-corp , News-ratings-for-acurx-pharmaceuticals-daily , Osaic-holdings-inc , Acurx-pharmaceuticals-stock-down , Global-capital , Acurx-pharmaceuticals , Institutional-trading-of-acurx-pharmaceuticals , Acurx-pharmaceuticals-inc

Acurx Pharmaceuticals (NASDAQ:ACXP) Earns Buy Rating from HC Wainwright

Acurx Pharmaceuticals (NASDAQ:ACXP) Earns Buy Rating from HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Osaic-holdings-inc , Acurx-pharmaceuticals-inc , News-ratings-for-acurx-pharmaceuticals-daily , Acurx-pharmaceuticals-stock-performance , Sigma-planning-corp , Acurx-pharmaceuticals , Northern-trust-corp , Blackrock-inc , Global-capital , Hedge-funds-weigh-in-on-acurx-pharmaceuticals , Get-free-report

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Sees Significant Decrease in Short Interest

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Sees Significant Decrease in Short Interest
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Osaic-holdings-inc , Global-capital , Acurx-pharmaceuticals-inc , Acurx-pharmaceuticals , Blackrock-inc , News-ratings-for-acurx-pharmaceuticals-daily , Acurx-pharmaceuticals-trading-down , Nasdaq , Get-free-report , Pharmaceuticals-trading-down , Acurx-pharmaceuticals-daily

Acurx Pharmaceuticals (NASDAQ:ACXP) Price Target Raised to $14.00 at HC Wainwright

Acurx Pharmaceuticals (NASDAQ:ACXP) Price Target Raised to $14.00 at HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Acurx-pharmaceuticals-trading , News-ratings-for-acurx-pharmaceuticals-daily , Blackrock-inc , Acurx-pharmaceuticals , Nasdaq , Osaic-holdings-inc , Acurx-pharmaceuticals-inc , Global-capital , Free-report , Get-free-report , Osaic-holdings

Critical Analysis: Acurx Pharmaceuticals (NASDAQ:ACXP) and Gain Therapeutics (NASDAQ:GANX)

Acurx Pharmaceuticals (NASDAQ:ACXP – Get Free Report) and Gain Therapeutics (NASDAQ:GANX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, profitability, dividends and analyst recommendations. Institutional & Insider Ownership 11.3% of Acurx […]

Switzerland , Staten-island , New-york , United-states , Maryland , Spain , News-ratings-for-acurx-pharmaceuticals-daily , Acurx-pharmaceuticals-inc , Gain-therapeutics-inc , Acurx-pharmaceuticals , Get-free-report

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Short Interest Update

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Short Interest Update
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Blackrock-inc , Acurx-pharmaceuticals-inc , Osaic-holdings-inc , Acurx-pharmaceuticals , Acurx-pharmaceuticals-stock-performance , Institutional-investors-weigh-in-on-acurx-pharmaceuticals , Global-capital , Nasdaq , News-ratings-for-acurx-pharmaceuticals-daily , Get-free-report , Osaic-holdings

Short Interest in Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Grows By 50.7%

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP – Get Free Report) was the recipient of a significant increase in short interest in the month of September. As of September 30th, there was short interest totalling 10,100 shares, an increase of 50.7% from the September 15th total of 6,700 shares. Currently, 0.1% of the company’s shares are sold short. […]

Global-capital , Institutional-trading-of-acurx-pharmaceuticals , Acurx-pharmaceuticals-company-profile , Nasdaq , Acurx-pharmaceuticals-stock , Blackrock-inc , News-ratings-for-acurx-pharmaceuticals-daily , Osaic-holdings-inc , Acurx-pharmaceuticals-inc , Acurx-pharmaceuticals , Get-free-report

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Short Interest Update

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP – Get Free Report) saw a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 6,700 shares, a drop of 51.1% from the August 31st total of 13,700 shares. Based on an average daily volume of 35,000 shares, the days-to-cover ratio […]

Nasdaq , Acurx-pharmaceuticals-inc , Acurx-pharmaceuticals , Blackrock-inc , Osaic-holdings-inc , Acurx-pharmaceuticals-price-performance , News-ratings-for-acurx-pharmaceuticals-daily , Global-capital , Get-free-report , Acurx-pharmaceuticals-daily , Nasdaq-acxp